Modeling the Protonation States of the Catalytic Aspartates in β-Secretase

β-Secretase (BACE) is a critical enzyme in the production of β-amyloid, a protein that has been implicated as a potential cause of Alzheimer's disease (AD). There are two aspartic acid residues (Asp 32 and Asp 228) present in the catalytic region of BACE that can adopt multiple protonation stat...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 47; no. 21; pp. 5159 - 5166
Main Authors Rajamani, Ramkumar, Reynolds, Charles H
Format Journal Article
LanguageEnglish
Published Washington, DC American Chemical Society 07.10.2004
Subjects
Online AccessGet full text
ISSN0022-2623
1520-4804
DOI10.1021/jm049817j

Cover

Abstract β-Secretase (BACE) is a critical enzyme in the production of β-amyloid, a protein that has been implicated as a potential cause of Alzheimer's disease (AD). There are two aspartic acid residues (Asp 32 and Asp 228) present in the catalytic region of BACE that can adopt multiple protonation states. The protonation state and precise location of the protons for these two residues, particularly in the presence of an inhibitor, are subjects of great interest since they have a direct bearing on the mechanism of aspartyl proteases and efforts to model β-secretase. We have carried out full liner-scaling quantum mechanical (QM) calculations that include Poisson−Boltzmann solvation in order to identify the preferred protonation state and proton location in the presence and absence of an inhibitor. These calculations favor the monoprotonated state in the presence of ligand, and di-deprotonated state in the absence of ligand. Further the proton in the monoprotonated state is located on the inner oxygen of Asp 228. These results have implications for the catalytic mechanism of BACE and related aspartyl proteases. They also provide a reference state for the protein in structure-based modeling studies of this therapeutically important target.
AbstractList β-Secretase (BACE) is a critical enzyme in the production of β-amyloid, a protein that has been implicated as a potential cause of Alzheimer's disease (AD). There are two aspartic acid residues (Asp 32 and Asp 228) present in the catalytic region of BACE that can adopt multiple protonation states. The protonation state and precise location of the protons for these two residues, particularly in the presence of an inhibitor, are subjects of great interest since they have a direct bearing on the mechanism of aspartyl proteases and efforts to model β-secretase. We have carried out full liner-scaling quantum mechanical (QM) calculations that include Poisson−Boltzmann solvation in order to identify the preferred protonation state and proton location in the presence and absence of an inhibitor. These calculations favor the monoprotonated state in the presence of ligand, and di-deprotonated state in the absence of ligand. Further the proton in the monoprotonated state is located on the inner oxygen of Asp 228. These results have implications for the catalytic mechanism of BACE and related aspartyl proteases. They also provide a reference state for the protein in structure-based modeling studies of this therapeutically important target.
Beta-secretase (BACE) is a critical enzyme in the production of beta-amyloid, a protein that has been implicated as a potential cause of Alzheimer's disease (AD). There are two aspartic acid residues (Asp 32 and Asp 228) present in the catalytic region of BACE that can adopt multiple protonation states. The protonation state and precise location of the protons for these two residues, particularly in the presence of an inhibitor, are subjects of great interest since they have a direct bearing on the mechanism of aspartyl proteases and efforts to model beta-secretase. We have carried out full liner-scaling quantum mechanical (QM) calculations that include Poisson-Boltzmann solvation in order to identify the preferred protonation state and proton location in the presence and absence of an inhibitor. These calculations favor the monoprotonated state in the presence of ligand, and di-deprotonated state in the absence of ligand. Further the proton in the monoprotonated state is located on the inner oxygen of Asp 228. These results have implications for the catalytic mechanism of BACE and related aspartyl proteases. They also provide a reference state for the protein in structure-based modeling studies of this therapeutically important target.Beta-secretase (BACE) is a critical enzyme in the production of beta-amyloid, a protein that has been implicated as a potential cause of Alzheimer's disease (AD). There are two aspartic acid residues (Asp 32 and Asp 228) present in the catalytic region of BACE that can adopt multiple protonation states. The protonation state and precise location of the protons for these two residues, particularly in the presence of an inhibitor, are subjects of great interest since they have a direct bearing on the mechanism of aspartyl proteases and efforts to model beta-secretase. We have carried out full liner-scaling quantum mechanical (QM) calculations that include Poisson-Boltzmann solvation in order to identify the preferred protonation state and proton location in the presence and absence of an inhibitor. These calculations favor the monoprotonated state in the presence of ligand, and di-deprotonated state in the absence of ligand. Further the proton in the monoprotonated state is located on the inner oxygen of Asp 228. These results have implications for the catalytic mechanism of BACE and related aspartyl proteases. They also provide a reference state for the protein in structure-based modeling studies of this therapeutically important target.
Beta-secretase (BACE) is a critical enzyme in the production of beta-amyloid, a protein that has been implicated as a potential cause of Alzheimer's disease (AD). There are two aspartic acid residues (Asp 32 and Asp 228) present in the catalytic region of BACE that can adopt multiple protonation states. The protonation state and precise location of the protons for these two residues, particularly in the presence of an inhibitor, are subjects of great interest since they have a direct bearing on the mechanism of aspartyl proteases and efforts to model beta-secretase. We have carried out full liner-scaling quantum mechanical (QM) calculations that include Poisson-Boltzmann solvation in order to identify the preferred protonation state and proton location in the presence and absence of an inhibitor. These calculations favor the monoprotonated state in the presence of ligand, and di-deprotonated state in the absence of ligand. Further the proton in the monoprotonated state is located on the inner oxygen of Asp 228. These results have implications for the catalytic mechanism of BACE and related aspartyl proteases. They also provide a reference state for the protein in structure-based modeling studies of this therapeutically important target.
Author Rajamani, Ramkumar
Reynolds, Charles H
Author_xml – sequence: 1
  givenname: Ramkumar
  surname: Rajamani
  fullname: Rajamani, Ramkumar
– sequence: 2
  givenname: Charles H
  surname: Reynolds
  fullname: Reynolds, Charles H
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16200650$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15456259$$D View this record in MEDLINE/PubMed
BookMark eNptkcFuEzEQhi3UiqaFAy-A9gISh6Vje9deH6uIQmkQQSniaE0cGxw2dmo7En0tHoRn6rZJGwn1MnOYb_6Z-eeYHIQYLCGvKLynwOjpcgWN6qhcPiMj2jKomw6aAzICYKxmgvEjcpzzEgA4Zfw5OaJt0wrWqhG5_BIXtvfhZ1V-2WqaYokBi4-hmhUsNlfR3VfGWLC_Kd5UZ3mNaVvzofr3t55Zk2zBbF-QQ4d9ti93-YR8P_9wNf5UT75-vBifTWrkUpVaMkMNM8j5HBCY6dA6hW4OClqmurZbyM5Kh9IoVENYOGEkc7bhTNC5A35C3m511yleb2wueuWzsX2PwcZN1kIoJgDoAL7egZv5yi70OvkVphv9cP4AvNkBmA32LmEwPu85wQBEezfx3ZYzKeacrNsjoO9eoB9fMLCn_7HGl3tLS0LfP9lRbzt8LvbPozSm31pILlt9NZ3pyaX6_O18CvrHfms0WS_jJoXB7Sd0bwGv26NX
CODEN JMCMAR
CitedBy_id crossref_primary_10_1039_D2RA06246A
crossref_primary_10_1021_jm300598e
crossref_primary_10_1002_ejoc_200801184
crossref_primary_10_1016_j_str_2005_06_015
crossref_primary_10_1038_s42003_023_05039_y
crossref_primary_10_1021_jm901408p
crossref_primary_10_1155_2014_598728
crossref_primary_10_1021_jm049133b
crossref_primary_10_1016_j_jmgm_2012_12_010
crossref_primary_10_3390_ijms232113098
crossref_primary_10_1016_j_febslet_2006_09_057
crossref_primary_10_1016_j_compbiomed_2022_105422
crossref_primary_10_1021_acs_jcim_7b00207
crossref_primary_10_1016_j_jmgm_2016_10_013
crossref_primary_10_1186_1472_6807_12_21
crossref_primary_10_1371_journal_pcbi_1004341
crossref_primary_10_1002_jcc_23547
crossref_primary_10_1021_ci200366z
crossref_primary_10_3109_14756366_2014_1003928
crossref_primary_10_1021_bi200081h
crossref_primary_10_1021_jm048973n
crossref_primary_10_1021_jm050138y
crossref_primary_10_1016_j_jmgm_2016_07_005
crossref_primary_10_1021_ci700223p
crossref_primary_10_1021_ct0600060
crossref_primary_10_1016_j_jmgm_2018_07_008
crossref_primary_10_1021_acs_jcim_4c01123
crossref_primary_10_1039_C6CP02097F
crossref_primary_10_1021_jp104983a
crossref_primary_10_1021_bi100637n
crossref_primary_10_1007_s00894_016_2926_z
crossref_primary_10_1016_j_jmgm_2016_10_006
crossref_primary_10_1016_j_febslet_2007_07_033
crossref_primary_10_1007_s10822_011_9443_z
crossref_primary_10_1016_j_jmgm_2017_07_010
crossref_primary_10_1016_j_drudis_2007_07_006
crossref_primary_10_1016_j_jmgm_2005_10_002
crossref_primary_10_1135_cccc2011035
crossref_primary_10_1016_j_jmgm_2016_04_003
crossref_primary_10_1021_acs_jpcb_4c04085
crossref_primary_10_1007_s00894_013_1821_0
crossref_primary_10_1021_jp811154w
crossref_primary_10_1021_acschemneuro_0c00813
crossref_primary_10_1007_s10059_009_0086_z
crossref_primary_10_1080_07391102_2017_1393461
crossref_primary_10_1016_j_bmcl_2008_10_096
crossref_primary_10_1002_jcc_24839
crossref_primary_10_1021_ja0573108
crossref_primary_10_1016_j_bbrc_2013_09_081
crossref_primary_10_1021_ci200611t
crossref_primary_10_1517_17460441_2_8_1129
crossref_primary_10_1002_ddr_20291
crossref_primary_10_1021_jm101568y
crossref_primary_10_1080_07391102_2018_1430619
crossref_primary_10_1016_j_chphi_2024_100754
crossref_primary_10_1016_j_jmgm_2017_06_001
crossref_primary_10_2174_1386207323999200918151331
crossref_primary_10_1016_j_bmcl_2006_11_003
crossref_primary_10_1021_jm301659n
Cites_doi 10.1006/jmbi.2000.4057
10.1146/annurev.bb.19.060190.001505
10.1126/science.290.5489.150
10.1021/bi010626h
10.1021/jm990412m
10.1016/S0006-3495(02)75209-0
10.1103/PhysRevB.47.10891
10.1006/jmbi.1996.0026
10.1110/ps.0305203
10.1063/1.1323257
10.1002/pro.5560010303
10.1021/jp990266w
10.1021/ci00012a014
10.1073/pnas.84.20.7009
10.1063/1.473579
10.1002/(SICI)1097-461X(1996)58:2<133::AID-QUA2>3.0.CO;2-Z
10.1021/bi00098a025
10.1021/bi00269a052
10.1074/jbc.M210471200
10.1006/mcne.1999.0811
10.2174/1568026024607490
10.1016/0165-6147(91)90609-V
10.1126/science.7761829
10.1126/science.2548279
10.1021/ja003145e
10.1021/bi00220a023
10.1016/S0197-4580(02)00122-7
10.1103/PhysRevB.50.17611
10.1016/S0166-1280(97)00358-8
10.1016/S0166-1280(97)00050-X
10.1021/ja00214a002
10.1007/BF00117280
10.1021/ja00023a046
10.1073/pnas.79.20.6142
10.1016/S0896-6273(00)00051-9
10.1002/poc.579
10.1021/bi00064a015
10.1152/physrev.2001.81.2.741
10.1016/S0022-2836(02)00197-3
10.1063/1.474404
10.1002/j.1460-2075.1989.tb08340.x
10.1021/jm020513b
10.1021/ar000184m
ContentType Journal Article
Copyright Copyright © 2004 American Chemical Society
2005 INIST-CNRS
Copyright_xml – notice: Copyright © 2004 American Chemical Society
– notice: 2005 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1021/jm049817j
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-4804
EndPage 5166
ExternalDocumentID 15456259
16200650
10_1021_jm049817j
ark_67375_TPS_LK9JQFP0_W
c000798597
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
.K2
53G
55A
5GY
5RE
5VS
7~N
9M8
AABXI
ABFLS
ABMVS
ABOCM
ABPTK
ABUCX
ACGFS
ACJ
ACS
AEESW
AENEX
AFEFF
AFFNX
ALMA_UNASSIGNED_HOLDINGS
ANTXH
AQSVZ
BAANH
CS3
DU5
EBS
ED
ED~
EJD
F5P
GJ
GNL
IH9
IHE
JG
JG~
K2
L7B
LG6
NHB
P2P
ROL
TN5
UI2
VF5
VG9
W1F
WH7
X
XFK
YZZ
ZGI
ZY4
---
-~X
.GJ
AAHBH
AAYOK
ABJNI
ABQRX
ABTAH
ACGFO
ADHLV
AGXLV
AHGAQ
BSCLL
CUPRZ
GGK
IH2
XSW
YQT
AAYXX
ABBLG
ABLBI
ACRPL
ADNMO
AEYZD
AGQPQ
ANPPW
CITATION
.55
.HR
1KJ
1WB
3EH
3O-
4.4
6P2
6TJ
ABHMW
ADXHL
IQODW
MVM
OHT
RNS
UBC
X7M
ZE2
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
YIN
7X8
ID FETCH-LOGICAL-a379t-72c1c2ca33b0a02c8aef9afb090529858d78e7fa7c9a97c9df6c72fe43261bf03
IEDL.DBID ACS
ISSN 0022-2623
IngestDate Thu Sep 04 21:32:08 EDT 2025
Wed Feb 19 01:47:22 EST 2025
Mon Jul 21 09:15:03 EDT 2025
Thu Apr 24 23:08:53 EDT 2025
Tue Jul 01 04:11:14 EDT 2025
Wed Oct 30 09:30:49 EDT 2024
Thu Aug 27 13:42:39 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 21
Keywords Peptidases
Structure activity relation
Enzyme
Active site
Molecular model
β-secretase
Hydrolases
Aspartate
Protonation
Mechanism of action
Modeling
Amyloid precursor protein
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a379t-72c1c2ca33b0a02c8aef9afb090529858d78e7fa7c9a97c9df6c72fe43261bf03
Notes ark:/67375/TPS-LK9JQFP0-W
istex:D73849ACC4C65DEC81C2664B505FD4EF243B17A5
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15456259
PQID 66926001
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_66926001
pubmed_primary_15456259
pascalfrancis_primary_16200650
crossref_primary_10_1021_jm049817j
crossref_citationtrail_10_1021_jm049817j
istex_primary_ark_67375_TPS_LK9JQFP0_W
acs_journals_10_1021_jm049817j
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
ACJ
VG9
W1F
ANTXH
ACS
AEESW
AFEFF
.K2
ABMVS
ABUCX
IH9
BAANH
AQSVZ
ED~
UI2
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-10-07
PublicationDateYYYYMMDD 2004-10-07
PublicationDate_xml – month: 10
  year: 2004
  text: 2004-10-07
  day: 07
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Journal of medicinal chemistry
PublicationTitleAlternate J. Med. Chem
PublicationYear 2004
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References Selkoe D. (jm049817jb00002/jm049817jb00002_1) 2001; 81
Hardy J. (jm049817jb00004/jm049817jb00004_1) 1991; 12
Trylska J. (jm049817jb00036/jm049817jb00036_1) 2002; 83
Stewart J. J. P (jm049817jb00049/jm049817jb00049_1) 1997; 401
Dixon S. L. (jm049817jb00042/jm049817jb00042_1) 1999
Hyland L. J. (jm049817jb00009/jm049817jb00009_1) 1991; 30
Silva A. M. (jm049817jb00037/jm049817jb00037_1) 1996; 255
Vassar R. (jm049817jb00001/jm049817jb00001_1) 2000; 27
Hussain I. (jm049817jb00008/jm049817jb00008_1) 1999; 14
Hyland L. J. (jm049817jb00039/jm049817jb00039_1) 1991; 30
Yang W. (jm049817jb00043/jm049817jb00043_1) 1995; 103
Yamazaki T. (jm049817jb00038/jm049817jb00038_1) 1994; 116
Veerapandian B. (jm049817jb00018/jm049817jb00018_1) 1992; 1
Gogonea V. (jm049817jb00054/jm049817jb00054_1) 1999; 103
Lee H. (jm049817jb00029/jm049817jb00029_1) 1996; 118
Venturini A. (jm049817jb00032/jm049817jb00032_1) 1998; 120
Leung D. (jm049817jb00007/jm049817jb00007_1) 2000; 43
Sharp K. (jm049817jb00051/jm049817jb00051_1) 1990; 19
van Gunsteren W. F. (jm049817jb00031/jm049817jb00031_1) 1998; 432
James M. N. G. (jm049817jb00013/jm049817jb00013_1) 1982; 79
Sali A. (jm049817jb00016/jm049817jb00016_1) 1989; 8
First Discovery (jm049817jb00057/jm049817jb00057_1)
Roggo A (jm049817jb00003/jm049817jb00003_1) 2002; 2
Cho Y. (jm049817jb00022/jm049817jb00022_1) 1994; 33
Piana S. (jm049817jb00033/jm049817jb00033_1) 2000
Coates L. (jm049817jb00019/jm049817jb00019_1) 2001; 40
Smith R. (jm049817jb00024/jm049817jb00024_1) 1996; 3
Jorgensen W. L. (jm049817jb00058/jm049817jb00058_1) 1988; 110
Beveridge A. J. (jm049817jb00025/jm049817jb00025_1) 1993; 32
Bott R. (jm049817jb00012/jm049817jb00012_1) 1982; 21
Schroeder S. (jm049817jb00059/jm049817jb00059_1) 1991; 113
Suguna K. (jm049817jb00015/jm049817jb00015_1) 1987; 84
Toulokhonova L. (jm049817jb00023/jm049817jb00023_1) 2003; 278
Foundling S. I. (jm049817jb00014/jm049817jb00014_1) 1987
Storer J. W. (jm049817jb00053/jm049817jb00053_1) 1995; 9
Harte W. E. (jm049817jb00026/jm049817jb00026_1) 1993; 115
Liu H. (jm049817jb00030/jm049817jb00030_1) 1996; 261
Li X. P. (jm049817jb00044/jm049817jb00044_1) 1993; 47
Li J. (jm049817jb00052/jm049817jb00052_1) 1998; 102
Citron M (jm049817jb00005/jm049817jb00005_1) 2002; 23
Diez (jm049817jb00060/jm049817jb00060_1) 2003; 16
Northrop D (jm049817jb00040/jm049817jb00040_1) 2001; 34
Goldblum A. (jm049817jb00028/jm049817jb00028_1) 1993; 33
Honig B. (jm049817jb00050/jm049817jb00050_1) 1995; 268
Wlodawer A. (jm049817jb00011/jm049817jb00011_1) 1989; 245
Park H. (jm049817jb00041/jm049817jb00041_1) 2003; 125
Piana S. (jm049817jb00034/jm049817jb00034_1) 2001; 123
Erskine P. T. (jm049817jb00021/jm049817jb00021_1) 2003; 12
Hong L. (jm049817jb00006/jm049817jb00006_1) 2000; 290
van der Vaart A. (jm049817jb00055/jm049817jb00055_1) 2000; 113
Yon J. (jm049817jb00056/jm049817jb00056_1) 2003
Cheng X. (jm049817jb00027/jm049817jb00027_1) 1995; 38
Nunes R. W. (jm049817jb00045/jm049817jb00045_1) 1994; 50
Millam J. M. (jm049817jb00047/jm049817jb00047_1) 1997; 106
Tounge B. A. (jm049817jb00061/jm049817jb00061_1) 2003; 46
Coates L. (jm049817jb00020/jm049817jb00020_1) 2002; 318
Ido E. (jm049817jb00010/jm049817jb00010_1) 1991; 266
Stewart J. J. P (jm049817jb00048/jm049817jb00048_1) 1996; 58
Jaskolski M. (jm049817jb00017/jm049817jb00017_1) 1991; 30
Wang W. (jm049817jb00035/jm049817jb00035_1) 2000; 303
Daniels A. D. (jm049817jb00046/jm049817jb00046_1) 1997; 107
References_xml – volume: 33
  start-page: 9642
  year: 1994
  ident: jm049817jb00022/jm049817jb00022_1
  publication-title: Biochemistry
– volume: 303
  start-page: 582
  year: 2000
  ident: jm049817jb00035/jm049817jb00035_1
  publication-title: J. Mol. Biol.
  doi: 10.1006/jmbi.2000.4057
– volume: 116
  start-page: 10792
  year: 1994
  ident: jm049817jb00038/jm049817jb00038_1
  publication-title: J. Am. Chem. Soc.
– volume: 19
  start-page: 332
  year: 1990
  ident: jm049817jb00051/jm049817jb00051_1
  publication-title: Annu. Rev. Biophys. Biophys. Chem.
  doi: 10.1146/annurev.bb.19.060190.001505
– volume: 290
  start-page: 153
  year: 2000
  ident: jm049817jb00006/jm049817jb00006_1
  publication-title: Science
  doi: 10.1126/science.290.5489.150
– volume: 40
  start-page: 13157
  year: 2001
  ident: jm049817jb00019/jm049817jb00019_1
  publication-title: Biochemistry
  doi: 10.1021/bi010626h
– volume: 3
  start-page: 950
  year: 1996
  ident: jm049817jb00024/jm049817jb00024_1
  publication-title: Nat. Struct. Biol.
– volume: 261
  start-page: 469
  year: 1996
  ident: jm049817jb00030/jm049817jb00030_1
  publication-title: J. Mol. Biol.
– volume: 43
  start-page: 341
  year: 2000
  ident: jm049817jb00007/jm049817jb00007_1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm990412m
– volume: 83
  start-page: 807
  year: 2002
  ident: jm049817jb00036/jm049817jb00036_1
  publication-title: Biophys. J.
  doi: 10.1016/S0006-3495(02)75209-0
– volume: 47
  start-page: 10891
  year: 1993
  ident: jm049817jb00044/jm049817jb00044_1
  publication-title: Phys. Rev. B
  doi: 10.1103/PhysRevB.47.10891
– volume: 125
  start-page: 16422
  year: 2003
  ident: jm049817jb00041/jm049817jb00041_1
  publication-title: J. Am. Chem. Soc.
– volume: 255
  start-page: 346
  year: 1996
  ident: jm049817jb00037/jm049817jb00037_1
  publication-title: J. Mol. Biol.
  doi: 10.1006/jmbi.1996.0026
– volume: 12
  start-page: 1749
  year: 2003
  ident: jm049817jb00021/jm049817jb00021_1
  publication-title: Protein Sci.
  doi: 10.1110/ps.0305203
– volume: 113
  start-page: 10523
  year: 2000
  ident: jm049817jb00055/jm049817jb00055_1
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.1323257
– volume: 1
  start-page: 328
  year: 1992
  ident: jm049817jb00018/jm049817jb00018_1
  publication-title: Protein Sci.
  doi: 10.1002/pro.5560010303
– volume: 103
  start-page: 5188
  year: 1999
  ident: jm049817jb00054/jm049817jb00054_1
  publication-title: J. Phys. Chem. A
  doi: 10.1021/jp990266w
– volume-title: Funct., Genet.
  year: 2000
  ident: jm049817jb00033/jm049817jb00033_1
– volume: 33
  start-page: 274
  year: 1993
  ident: jm049817jb00028/jm049817jb00028_1
  publication-title: J. Chem. Inf. Comput. Sci.
  doi: 10.1021/ci00012a014
– volume: 84
  start-page: 7013
  year: 1987
  ident: jm049817jb00015/jm049817jb00015_1
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.84.20.7009
– volume: 106
  start-page: 5569
  year: 1997
  ident: jm049817jb00047/jm049817jb00047_1
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.473579
– volume: 58
  start-page: 133
  year: 1996
  ident: jm049817jb00048/jm049817jb00048_1
  publication-title: Int. J. Quantum Chem.
  doi: 10.1002/(SICI)1097-461X(1996)58:2<133::AID-QUA2>3.0.CO;2-Z
– volume: 30
  start-page: 8463
  year: 1991
  ident: jm049817jb00009/jm049817jb00009_1
  publication-title: Biochemistry
  doi: 10.1021/bi00098a025
– volume: 21
  start-page: 6962
  year: 1982
  ident: jm049817jb00012/jm049817jb00012_1
  publication-title: Biochemistry
  doi: 10.1021/bi00269a052
– volume: 266
  start-page: 24366
  year: 1991
  ident: jm049817jb00010/jm049817jb00010_1
  publication-title: J. Biol. Chem.
– volume: 278
  start-page: 4589
  year: 2003
  ident: jm049817jb00023/jm049817jb00023_1
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M210471200
– volume: 14
  start-page: 427
  year: 1999
  ident: jm049817jb00008/jm049817jb00008_1
  publication-title: Mol. Cell. Neurosci.
  doi: 10.1006/mcne.1999.0811
– volume: 2
  start-page: 370
  year: 2002
  ident: jm049817jb00003/jm049817jb00003_1
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/1568026024607490
– volume: 38
  start-page: 48
  year: 1995
  ident: jm049817jb00027/jm049817jb00027_1
  publication-title: J. Med. Chem.
– volume: 103
  start-page: 5678
  year: 1995
  ident: jm049817jb00043/jm049817jb00043_1
  publication-title: J. Chem. Phys.
– start-page: 327
  year: 1987
  ident: jm049817jb00014/jm049817jb00014_1
  publication-title: Nature
– volume: 12
  start-page: 388
  year: 1991
  ident: jm049817jb00004/jm049817jb00004_1
  publication-title: Trends Pharmacol.
  doi: 10.1016/0165-6147(91)90609-V
– volume-title: version 2.0
  ident: jm049817jb00057/jm049817jb00057_1
– volume: 115
  start-page: 3886
  year: 1993
  ident: jm049817jb00026/jm049817jb00026_1
  publication-title: J. Am. Chem. Soc.
– volume: 268
  start-page: 1149
  year: 1995
  ident: jm049817jb00050/jm049817jb00050_1
  publication-title: Science
  doi: 10.1126/science.7761829
– volume-title: PA
  year: 1999
  ident: jm049817jb00042/jm049817jb00042_1
– volume: 245
  start-page: 621
  year: 1989
  ident: jm049817jb00011/jm049817jb00011_1
  publication-title: Science
  doi: 10.1126/science.2548279
– volume: 123
  start-page: 8737
  year: 2001
  ident: jm049817jb00034/jm049817jb00034_1
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja003145e
– volume: 30
  start-page: 1609
  year: 1991
  ident: jm049817jb00017/jm049817jb00017_1
  publication-title: Biochemistry
  doi: 10.1021/bi00220a023
– volume: 23
  start-page: 1022
  year: 2002
  ident: jm049817jb00005/jm049817jb00005_1
  publication-title: Neurobiol. Aging
  doi: 10.1016/S0197-4580(02)00122-7
– start-page: 272
  volume-title: PCT Int. Appl
  year: 2003
  ident: jm049817jb00056/jm049817jb00056_1
– volume: 50
  start-page: 17611
  year: 1994
  ident: jm049817jb00045/jm049817jb00045_1
  publication-title: Phys. Rev. B
  doi: 10.1103/PhysRevB.50.17611
– volume: 432
  start-page: 14
  year: 1998
  ident: jm049817jb00031/jm049817jb00031_1
  publication-title: J. Mol. Struct.
  doi: 10.1016/S0166-1280(97)00358-8
– volume: 401
  start-page: 195
  year: 1997
  ident: jm049817jb00049/jm049817jb00049_1
  publication-title: J. Mol. Struct. (THEOCHEM)
  doi: 10.1016/S0166-1280(97)00050-X
– volume: 110
  start-page: 1666
  year: 1988
  ident: jm049817jb00058/jm049817jb00058_1
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja00214a002
– volume: 30
  start-page: 8453
  year: 1991
  ident: jm049817jb00039/jm049817jb00039_1
  publication-title: Biochemistry
– volume: 9
  start-page: 110
  year: 1995
  ident: jm049817jb00053/jm049817jb00053_1
  publication-title: J. Comput. Aided Mol. Des.
  doi: 10.1007/BF00117280
– volume: 113
  start-page: 8925
  year: 1991
  ident: jm049817jb00059/jm049817jb00059_1
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja00023a046
– volume: 118
  start-page: 3950
  year: 1996
  ident: jm049817jb00029/jm049817jb00029_1
  publication-title: J. Am. Chem. Soc.
– volume: 102
  start-page: 1831
  year: 1998
  ident: jm049817jb00052/jm049817jb00052_1
  publication-title: J. Phys. Chem.
– volume: 79
  start-page: 6142
  year: 1982
  ident: jm049817jb00013/jm049817jb00013_1
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.79.20.6142
– volume: 27
  start-page: 422
  year: 2000
  ident: jm049817jb00001/jm049817jb00001_1
  publication-title: Neuron
  doi: 10.1016/S0896-6273(00)00051-9
– volume: 16
  start-page: 107
  year: 2003
  ident: jm049817jb00060/jm049817jb00060_1
  publication-title: J. Phys. Org. Chem.
  doi: 10.1002/poc.579
– volume: 32
  start-page: 3333
  year: 1993
  ident: jm049817jb00025/jm049817jb00025_1
  publication-title: Biochemistry
  doi: 10.1021/bi00064a015
– volume: 81
  start-page: 766
  year: 2001
  ident: jm049817jb00002/jm049817jb00002_1
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.2001.81.2.741
– volume: 318
  start-page: 1415
  year: 2002
  ident: jm049817jb00020/jm049817jb00020_1
  publication-title: J. Mol. Biol.
  doi: 10.1016/S0022-2836(02)00197-3
– volume: 107
  start-page: 425
  year: 1997
  ident: jm049817jb00046/jm049817jb00046_1
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.474404
– volume: 8
  start-page: 2188
  year: 1989
  ident: jm049817jb00016/jm049817jb00016_1
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1989.tb08340.x
– volume: 46
  start-page: 2082
  year: 2003
  ident: jm049817jb00061/jm049817jb00061_1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm020513b
– volume: 120
  start-page: 1111
  year: 1998
  ident: jm049817jb00032/jm049817jb00032_1
  publication-title: J. Am. Chem. Soc.
– volume: 34
  start-page: 797
  year: 2001
  ident: jm049817jb00040/jm049817jb00040_1
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar000184m
SSID ssj0003123
Score 2.09425
Snippet β-Secretase (BACE) is a critical enzyme in the production of β-amyloid, a protein that has been implicated as a potential cause of Alzheimer's disease (AD)....
Beta-secretase (BACE) is a critical enzyme in the production of beta-amyloid, a protein that has been implicated as a potential cause of Alzheimer's disease...
SourceID proquest
pubmed
pascalfrancis
crossref
istex
acs
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 5159
SubjectTerms Amyloid Precursor Protein Secretases
Analytical, structural and metabolic biochemistry
Aspartic Acid - chemistry
Biological and medical sciences
Catalysis
Catalytic Domain
Endopeptidases - chemistry
Enzyme Inhibitors - chemistry
Enzymes and enzyme inhibitors
Fundamental and applied biological sciences. Psychology
Hydrolases
Medical sciences
Miscellaneous
Models, Molecular
Pharmacology. Drug treatments
Propionates - chemistry
Protons
Quantum Theory
Title Modeling the Protonation States of the Catalytic Aspartates in β-Secretase
URI http://dx.doi.org/10.1021/jm049817j
https://api.istex.fr/ark:/67375/TPS-LK9JQFP0-W/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/15456259
https://www.proquest.com/docview/66926001
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVABC
  databaseName: American Chemical Society Journals
  customDbUrl:
  eissn: 1520-4804
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0003123
  issn: 0022-2623
  databaseCode: ACS
  dateStart: 19630101
  isFulltext: true
  titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals
  providerName: American Chemical Society
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1fb9MwED-N7QFeGAwY3WBYgCoeluHYif88ToVq2hAKaif2FjmuLbFBMjWptO5j8UH4TNhx0zKxwUsUKWcrts--n33n3wG8VYkShRE4MtKfViUqjaSVJpqYRFPGrGco9NEWn9nRaXJ8lp6twZs7PPgkfn_-w4FYEfPze7BBmHvx-GcwWi63NCa0owQnzph39EF_FvWmR9c3TM-G78UrHwqpatcbNqSxuBtntvZmuAkfuls7Iczk4mDWFAf6-m8Sx3815RE8XOBNdBgU5DGsmXIL7g-6NG9b0M8CefV8H41Xd7HqfdRH2YrWev4ETnzaNH95HTnMiLJp1VThJBEFwIoq234Z-AOhuasDHbrVahq-fSvRr5_RyGPUxtnNp3A6_DgeHEWLVAyRolw2ESc61kQrSgusMNFCGSuVLbD0nkKRigkXhlvFtVTSPSaWaU6sSRw6jAuL6TNYL6vSPAekpODGCmcGDU2MpAJT7irShNmJiou0B3turPLFVKrz1ktO3C6l67wevOuGMdcLInOfT-P7baKvl6KXgb3jNqF-qwtLCTW98OFuPM3H2Sj_dCKPvwwznH91f3ZDWVZVMtJC3R686rQnd6PoXS-qNNWszhmTPhNA3IPtoFSrsmnYg-78r9m78CCQTOII8xew3kxn5qUDRE2x106I3_5CBKs
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgexgvDMatDDYLoYqHZXPiJLYfp4qqrGUKaif2ZjmuLbFLgppUWvez-CH8JnxJGoaG4CUvPrac42Ofzz72dwB4L2JBc0VRoJg9rYpFEjDNVDBXscRpqi1Dob1tcZqOzuKT8-S8ocmxb2FMJyrTUuWC-B27QHh0cW2wLA3JxUOw6RhQLAwaTNerLg4j3DKDR8antyxCv1e1HkhWdzzQplXmjb0RKSqjFO2zWfwdbjq3M9z2-Ytch91tk8vDZZ0fyts_uBz_74-egMcN-oTH3lyeggeq2AFbgzbp2w7oZ57KenUAZ93LrOoA9mHWkVyvnoGxTaJmn7JDgyBhtijr0p8rQg9fYaldycAeD61MG_DYrF0LX_atgD9_BFOLWGvjRZ-Ds-HH2WAUNIkZAoEJqwMSyVBGUmCcI4EiSYXSTOgcMRs3pAmdE6qIFkQywcxnrlNJIq1igxXDXCP8AmwUZaFeASgYJUpT4xQVjhXDFGFiGpJRqucizJMe2DO6483EqriLmUdmz9Iqrwc-tKPJZUNrbrNrXN0n-m4t-t1zedwn1HcmsZYQi0t7-Y0kfJZN-WTMTr4MM8S_mp7dsZmuyTRywLcH9lsj4mYUbSBGFKpcVjxNmc0LEPbAS29bXd3E70hf_-u398HWaPZ5wiefTse74JGnn0QBIm_ARr1YqrcGKtX5npsjvwCm_A0W
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwEB5BKwEXfgqF5ae1EFpxaEoSJ7F9rBZWpVuVoN2K3iLHsSVaSKpNVmJ5LB6EZ8ITJ7sUFcElF48tZzz2fPbY3wC8kpHkuea-pwWeVkUy9oQR2it0pGiSGGQoxNsWJ8nhaXR0Fp91G0V8C2M7UduW6jaIj7P6sjAdw0Dw5vyrxbM8YOc3YTNG6jeEQqPpauWlQUh7dvDQ-vWeSej3quiFVH3FC22iQr_hrUhZW8UYl9Hi75CzdT3je_Bh1en2xsnF_qLJ99X3P_gc__-v7sPdDoWSA2c2D-CGLrfg9qhP_rYFw9RRWi_3yGz9QqveI0OSrsmulw9hgsnU8Ek7sUiSpPOqqdz5InEwllSmLRnhMdHStkEO7Bo2d2WfS_LzhzdF5NpYb_oITsfvZqNDr0vQ4EnKROOxUAUqVJLS3Jd-qLjURkiT-wLjhzzmBeOaGcmUkMJ-CpMoFhodWcwY5Man27BRVqV-AkQKzrTh1jlqGmlBuU-ZbUiFiSlkkMcD2LH6y7oJVmdt7Dy0e5deeQN43Y9opjp6c8yy8eU60Zcr0UvH6XGd0LA1i5WEnF_gJTgWZ7N0mh1PxNHHcepnn2zPrtjNuskkbAHwAHZ7Q8rsKGJARpa6WtRZkgjMDxAM4LGzr3Xd2O1Mn_7rt3fhVvp2nB2_P5k8gzuOhdL3fPYcNpr5Qr-wiKnJd9pp8gtBlw-Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modeling+the+protonation+states+of+the+catalytic+aspartates+in+%CE%B2-secretase&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=RAJAMANI%2C+Ramkumar&rft.au=REYNOLDS%2C+Charles+H&rft.date=2004-10-07&rft.pub=American+Chemical+Society&rft.issn=0022-2623&rft.volume=47&rft.issue=21&rft.spage=5159&rft.epage=5166&rft_id=info:doi/10.1021%2Fjm049817j&rft.externalDBID=n%2Fa&rft.externalDocID=16200650
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon